3rd Quarter - Report
MADRIGAL PHARMACEUTICALS, INC. for MADRIGAL PHARMACEUTICALS, INC.
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to CMMI drug pricing; 340B drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA WALKER RIEMER | — |
Health Issues HCR
Most Favored Nation drug pricing; Issues related to CMMI drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA WALKER RIEMER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.